Menopausal hormone therapy may increase risk of ovarian cancer

Nov 09, 2010

Women planning on taking hormone therapy for the treatment of menopausal symptoms should be aware of a possible increased risk for ovarian cancer, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.

"This study is consistent with previous recommendations that say if women are going to take hormones they should only take them in the short term," said Konstantinos Tsilidis, Ph.D., a postdoctoral fellow at the Cancer Epidemiology Unit at the University of Oxford.

Tsilidis and colleagues analyzed the European Prospective Investigation into Cancer and Nutrition, which included 126,920 women, of whom 424 were diagnosed with ovarian cancer over nine years of follow-up.

Although former use of hormone therapy was not associated with increased risk, current use of hormone therapy was linked with a 29 percent increased risk.

Risk levels did not differ by type of hormone therapy (estrogen only vs. plus progestin), specific hormonal constituents, regimens and routes of administration of , or by histology.

Explore further: New study demonstrates advances in creating treatment for common childhood blood cancer

add to favorites email to friend print save as pdf

Related Stories

Hormone therapy raises cancer risk

Jan 16, 2008

Menopausal women who take hormone combinations for their symptoms are more likely to get an uncommon type of breast cancer much earlier than experts believed.

Study links obesity to elevated risk of ovarian cancer

Jan 05, 2009

A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. Published in the ...

Recommended for you

User comments : 0